| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |